Weight Loss Telehealth in Pennsylvania 2026 15 Providers Compared, Ranked, and Priced

Fifteen telehealth providers are currently accepting Pennsylvania residents for weight loss treatment in 2026. That is a strong number compared to many states, and it means you have real competition working in your favor when it comes to price. Three providers you might see mentioned elsewhere, Clinic Secret, Nurx, and UrWay Health, do not operate in Pennsylvania, so ignore any content that recommends them to you.

The 15 providers available to you are Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. They range from dedicated weight loss specialists charging under $200 per month all-inclusive to broad primary care platforms that bill your insurance directly. The right one depends on whether you are insured, what medication you want, and how much support you want beyond a prescription.

If you are just starting your search and want the short answer: Medvi is rated our top choice for most Pennsylvania residents because it combines one of the lowest all-inclusive prices in the state ($149 to $199 per month for compounded semaglutide) with a 8.9/10 rating from over 33,200 verified reviews. Ro is the better call if you want help getting brand-name Wegovy or Ozempic covered by your commercial insurance. MyStart Health is the pick if this is your first time using a GLP-1 and you want hand-holding through the process.

Pennsylvania does not have an insurance parity law that forces health plans to cover weight loss medications. That matters a lot. In states with parity requirements, your insurer has less legal wiggle room to deny GLP-1 coverage. In Pennsylvania, a commercial plan can simply exclude semaglutide or tirzepatide from its formulary and there is no state mandate compelling them to add it. If you have employer-sponsored insurance, check your Summary of Benefits and Coverage document specifically for 'anti-obesity medications' or 'GLP-1 agonists' before assuming you are covered.

Pennsylvania Medicaid does not generally cover GLP-1 weight loss medications. If you are on Medicaid, your realistic options are compounded semaglutide through a cash-pay telehealth provider, older medications like phentermine or metformin, or the combination medication bupropion-naltrexone, which has different coverage rules. Do not count on any of the 15 providers here to bill Medicaid for a GLP-1 injection or oral medication.

Phentermine is a controlled substance, and this matters in Pennsylvania. State law requires that a prescriber have a valid patient-provider relationship and conduct a proper clinical evaluation before issuing a controlled substance prescription. Most telehealth platforms in Pennsylvania can prescribe phentermine after a synchronous video visit, but not after an asynchronous questionnaire-only intake. If a provider offers you phentermine without ever speaking to a live clinician, that should raise a flag. Compounded semaglutide and tirzepatide are not controlled substances, so the intake process for those is generally simpler and can be completed asynchronously on most platforms.

Compounded GLP-1 medications are available in Pennsylvania through licensed 503B outsourcing facilities, which are FDA-regulated compounding pharmacies. The FDA declared the Zepbound and Wegovy shortages resolved in December 2024 and February 2025, ending its shortage-era enforcement discretion; compounded availability now depends on patient-specific clinical need. That means compounded semaglutide and compounded tirzepatide are legally accessible to Pennsylvania residents through telehealth. If the FDA's enforcement posture changes, compounded availability could tighten, but for now you have a legal, lower-cost pathway through providers like Medvi, Sprout Health, Skinny.Rx, and Shed.

Pennsylvania residents can access the full spectrum of weight loss medications through telehealth in 2026. Here is what is on the table and which providers carry each one.

Compounded semaglutide is the most widely prescribed option through cash-pay telehealth in Pennsylvania. It is the same active molecule as Ozempic and Wegovy but manufactured by a 503B compounding pharmacy rather than Novo Nordisk. Medvi, Sprout Health, Skinny.Rx, Shed, and MyStart Health all offer this. Pricing ranges from around $149 per month at Medvi to around $200 per month at Sprout Health and Shed. The all-inclusive pricing at Medvi and MyStart Health means the medication, provider visit, and follow-up care are bundled together, which simplifies budgeting.

Brand-name Wegovy and Ozempic are available through Ro and Henry Meds. Both platforms are built specifically to help you work the insurance angle. Ro has a dedicated insurance navigation team that will check your commercial plan's prior authorization requirements and help you submit the paperwork. Henry Meds works directly with insurance for Ozempic and other GLP-1s and is worth contacting if you have a commercial plan with diabetes coverage, since Ozempic's diabetes indication sometimes gets through when Wegovy's obesity indication does not.

Compounded tirzepatide (same active molecule as Zepbound and Mounjaro) is available through several of the same providers offering compounded semaglutide. If you have tried semaglutide before or your provider suggests tirzepatide as a better clinical fit, ask specifically which platforms can source it from their 503B partner pharmacy. Pricing for compounded tirzepatide typically runs $50 to $100 higher per month than compounded semaglutide.

Phentermine, metformin, liraglutide, and bupropion-naltrexone are also available in Pennsylvania. Phentermine is the lowest-cost option, sometimes under $50 per month, but it is short-term by design and not appropriate for everyone. PlushCare and Sesame Care, both of which have actual primary care physicians in their networks, are good places to discuss non-GLP-1 options if you are not a candidate for semaglutide or prefer a different approach. Sesame Care's pay-per-visit model means you are not locked into a subscription to have that conversation.

The cheapest route for a cash-paying Pennsylvania resident is Medvi. At $149 to $199 per month all-inclusive for compounded semaglutide, it undercuts most of the competition while maintaining a 8.9/10 rating from over 33,200 reviews. There are no separate consultation fees, no pharmacy shipping costs added at checkout, and no upsells for coaching that should be part of the base program. If your priority is keeping costs down and you are comfortable with a no-frills experience, start here.

If you want insurance help and have commercial coverage, go to Ro first. Ro's clinical team has specific experience handling the prior authorization process for brand-name GLP-1s and knows the documentation requirements that commercial insurers typically demand. Their 8.9/10 rating from 32,100 verified reviews reflects consistent service quality. If Ro cannot get your plan to cover it, they can also move you to a compounded option so you do not waste months going back and forth with your insurer before starting treatment.

For Pennsylvania women who want a weight loss program that also addresses hormonal context, stress, or related health concerns alongside the medication, Hers is worth a serious look. It is the sister brand to Hims, covers weight loss alongside birth control, hair loss, and mental health, and carries an 8.8/10 rating from 29,800 reviews. Having a single provider relationship that understands your full picture is genuinely useful if you are managing multiple health concerns at once.

If you are completely new to GLP-1 medications and want more guidance than a standard telehealth intake provides, MyStart Health is rated Best for Beginners for a reason. It includes lifestyle coaching alongside GLP-1 prescribing and walks you through titration in a way that feels more supported. For people who have never injected a medication before or who want someone to help them interpret side effects in the first few weeks, that structure is worth paying slightly more than Medvi's rock-bottom price.

PlushCare is the right call if you want a primary care relationship that bills your insurance, not just a weight loss prescription. It takes insurance directly and covers mental health, general primary care, and weight loss under one roof. If you have a Blue Cross, Aetna, or UPMC commercial plan in Pennsylvania and want to work through your existing coverage rather than paying out of pocket, PlushCare is the most insurance-integrated option on this list.

Cash-pay pricing for compounded semaglutide in Pennsylvania ranges from $149 per month at Medvi up to roughly $299 per month depending on the provider and what is bundled. Medvi and MyStart Health are explicit about all-inclusive pricing. Sprout Health, Shed, and Skinny.Rx all sit in the $150 to $250 range. Some providers charge separately for the initial consultation, which can add $50 to $100 to your first month's cost, so always check whether the consultation fee is included before signing up.

Brand-name Wegovy without insurance runs between $1,350 and $1,500 per month at retail in Pennsylvania. That is not a realistic cash-pay option for most people. Novo Nordisk has a savings card program that can bring the cost down to $0 or $25 per month if you have qualifying commercial insurance, but that only works if your plan actually covers Wegovy in the first place. This is where Ro's insurance navigation adds real value because getting through prior auth can mean the difference between $199 per month and $1,400 per month.

Sesame Care operates on a pay-per-visit model with transparent pricing, which makes it unusual on this list. You might pay $75 to $150 for a weight loss consultation with a Pennsylvania-licensed physician, then pay separately for your medication at any pharmacy. There is no subscription, no monthly program fee. If you just want to talk to a doctor once, get a prescription, and fill it yourself, Sesame Care's model fits. It is also worth using if you are unsure which medication you want and want a no-commitment consultation first.

Henry Meds is worth a separate call-out on cost because it specifically works with insurance for Ozempic. If you have a commercial plan with any diabetes-adjacent coverage, Henry Meds may be able to get you Ozempic under a different indication pathway than Wegovy. The out-of-pocket experience varies significantly by plan, but their 8.6/10 rating from 12,600 reviews suggests they deliver on the insurance navigation promise more often than not.

Searching 'semaglutide telehealth Pennsylvania' will return dozens of options, but the actual clinical process is more standardized than the marketing suggests. Every legitimate provider must confirm you meet a basic clinical threshold before prescribing. The standard is a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea. You will need to answer health history questions and in most cases provide some documentation of your current weight and health status.

For compounded semaglutide through providers like Medvi, Sprout Health, or Shed, the intake is typically asynchronous. You complete a questionnaire, a Pennsylvania-licensed physician or nurse practitioner reviews it, and a prescription is issued if you qualify. The medication is shipped directly to your Pennsylvania address from the 503B pharmacy the provider works with. First shipment usually arrives within five to seven business days after approval.

For brand-name Wegovy through Ro, the process involves the insurance verification step before you even get to the prescription. Ro's team checks your plan's formulary and prior auth requirements in parallel with your clinical intake. If you have been diagnosed with obesity or a qualifying comorbidity by a physician before, having that documentation ready will speed up the process significantly. A prior chart note or lab work showing your BMI and any comorbidities is the single most useful thing you can bring to a brand-name GLP-1 intake.

Once you are on semaglutide, dose titration typically starts at 0.25mg per week and increases every four weeks up to a maintenance dose. The telehealth providers on this list all handle follow-up differently. MyStart Health and Sprout Health include structured follow-up in their monthly price. Medvi keeps it simple but does allow follow-up messaging. If you want a provider who will actively monitor your progress and adjust your dose, choose one that explicitly advertises ongoing care in their pricing rather than assuming follow-up is included.

Pennsylvania has no parity requirement for weight loss medications, and Medicaid does not cover GLP-1s for most residents. That means if you are uninsured or on Medicaid, you are almost certainly paying out of pocket. The good news is that the cash-pay market in Pennsylvania is competitive enough that you have real options that do not require insurance.

Medvi at $149 per month is the floor for a full-service compounded semaglutide program in Pennsylvania. That price includes the medication, shipping, and ongoing clinical oversight. For context, this is less than many gym memberships and gym memberships do not come with a GLP-1 prescription. Skinny.Rx offers a similarly streamlined budget option if Medvi is ever at capacity or you want a second quote.

If even $149 per month is a stretch, the non-GLP-1 medications are worth asking about. Phentermine prescribed through PlushCare or Sesame Care can cost under $50 per month for the medication after a single paid consultation. Metformin, which has some evidence for modest weight loss and is very well tolerated, costs almost nothing as a generic. These are not as effective as GLP-1s for most people, but they are real clinical options with legitimate prescribers behind them.

One Pennsylvania-specific resource worth knowing about: the University of Pittsburgh Medical Center (UPMC) and Penn Medicine both run clinical weight management programs that sometimes have sliding-scale fee structures. If you are in Philadelphia, Pittsburgh, or a surrounding metro area, checking directly with these systems may reveal subsidized programs that are not visible in a standard telehealth search. Telehealth is often the right call, but it is not the only one.

Ratings matter when you are choosing a provider you will interact with monthly for potentially a year or more. Among the 15 Pennsylvania-available providers, Hims and Strut share the top rating at 9.0/10, from 34,200 and 38,500 verified reviews respectively. Hims is the better weight loss choice of the two since Strut is primarily focused on hair loss and men's health formulations. Medvi and Ro both sit at 8.9/10 with large review bases, which means those ratings are statistically meaningful rather than inflated by a small sample.

Ivim Health has the lowest rating on this list at 8.0/10 from 6,800 reviews, and its specialty is TRT and metabolic health rather than weight loss per se. If weight loss is your primary goal, Ivim is not the first place to start. Peter MD at 8.4/10 is a men's health specialist that does cover weight loss, but it is better suited to someone who also wants to address testosterone or ED under one platform rather than someone whose sole focus is semaglutide.

Shed and Skinny.Rx both have smaller review pools, 7,500 and 4,378 respectively, compared to providers like Hims or Medvi. Smaller sample sizes do not automatically mean worse service, but they do mean the ratings are less statistically robust. If you choose either, look for recent reviews specifically from Pennsylvania residents if the platform allows filtering by state.

For purely weight loss-focused care with the strongest combination of price, rating, and review volume in Pennsylvania, the ranking looks like this: Medvi first for cash-pay simplicity, Ro first for insurance navigation, MyStart Health first for beginners, and PlushCare first if you want insurance-billed primary care. Every other provider on the list has a niche where it performs well, but those four cover the use cases that account for the majority of what Pennsylvania residents are actually searching for.

Pennsylvania has a significant rural population, and the experience of accessing weight loss telehealth from a rural county in central or northern Pennsylvania is meaningfully different from accessing it in Philadelphia or Pittsburgh. This is not about which providers are available, all 15 serve the entire state. It is about the pharmacy logistics behind the medication.

Compounded semaglutide is shipped directly from 503B pharmacies, and most of those facilities are in major metro areas in other states. For rural Pennsylvania residents, this means your medication arrives by mail, typically FedEx or UPS with temperature-controlled packaging. That works fine most of the year, but in winter months in counties like Cameron, Potter, or Sullivan, delayed deliveries due to weather can disrupt your dosing schedule. When you sign up with any of these providers, ask specifically about their cold-chain shipping policy and what happens if a package is delayed or damaged in transit. Medvi, Sprout Health, and Shed all ship this way, and it is a routine process, but it is worth confirming replacement policies before you commit.

For rural Pennsylvania residents who want to minimize shipping dependency, PlushCare and Sesame Care are worth considering because they can send prescriptions to a local pharmacy of your choice rather than relying entirely on mail-order compounded medications. If you live within driving distance of a retail pharmacy chain that stocks brand-name Wegovy or Zepbound (Walmart, CVS, Rite Aid, and Giant Eagle all have locations throughout rural Pennsylvania), having a prescription sent there gives you more control over your supply chain than mail-order compounding does.

This is a practical consideration that has nothing to do with clinical quality and everything to do with the reality of living in a state where February can bring two feet of snow to the northern tier. Plan for it before you start, not after your first shipment goes missing.